E. Graf, M. W. Hosseini et al.
1257.29 (44) [MÀH]+, 958.13 (46) [19ÀSnÀC14H10O3]+, 733.14 (10)
[19ÀSn]+.
ment with a PdII salt, leads to the formation of the neutral
palladium complex 3–Pd. The formation of the latter, result-
ing from the simultaneous binding of the cation by both the
deprotonated tridentate unit and the pyridyl group, gener-
ates the closed state of the turnstile. Again, the system may
be opened upon addition of CNÀ anions as competitive li-
gands.
Work on analogous systems with several coordinating
sites located at the meso positions of the porphyrin back-
bone is currently under progress.
Synthesis of 3: Under argon, a solution of 12 (35.3 mg, 0.057 mmol,
1.1 equiv) in dry CHCl3 (40 mL) was added dropwise, by using a cannula,
to a solution of 21 (40.1 mg, 0.052 mmol, 1 equiv) in dry CHCl3 (30 mL).
The resulting mixture was stirred at room temperature for 4 days. Evolu-
tion of the reaction was monitored by 1H NMR spectroscopy. After re-
moval of the solvent, the residue was recrystallised from toluene/pentane
(12 mL/60 mL) to afford a deep red–purple powder (63.9 mg, 91%).
Single crystals suitable for X-ray analysis were obtained by slow diffusion
of pentane into a solution of 3 in dichloromethane. 1H NMR (400 MHz,
CD2Cl2) (assignments according to COSY and ROESY 2D 1H–1H NMR
experiments): d=1.26 (t, 4J
7.9, 4J(H,H)=2.1 Hz, 2H; Hn), 3.20 (t, 3J
(t, 3J
(H,H)=4.6 Hz, 4H; Hq2), 3.56 (m, 4H; Hq6), 3.67–3.71 (m, 12H;
A
ACHTUNGTRENNUNG(H,H)=
A
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
Experimental Section
3
4
H
ACHTUNGTRENNUNG
q3, Hq4, Hq5), 5.35 (dd, J
(H,H)=8.0 Hz, 2H; Ho), 7.83–7.92 (m, 9H; Ha, Hb, Hg, Hh), 8.09 (t,
(H,H)=7.8 Hz, 1H; Ht), 8.22–8.25 (m, 6H; Hf, HL), 8.37–8.41 (m, 4H;
(H,H)=4.7, 4J
(Sn,H)=16.7 Hz, 2H; HJ), 9.13 (d,
(Sn,H)=16.7 Hz, 2H; Hi), 9.16 (dd, 3J
(H,H)=4.3,
(H,H)=1.3 Hz, 2H; Hk), 9.23 (m, 4H; He, Hw), 9.30 ppm (d, J
(Sn-H)=17.3 Hz, 2H; Hd); 13C NMR (100 MHz, CD2Cl2): d=(as-
ACHUTGTNREN(NGU H,H)=7.9, JHCATUTGNREN(NUGN H,H)=2.4 Hz, 2H; Hp), 5.54 (t,
3J
3J
General: Compounds 5, 7 and 9 were commercially available and used
without further purification. Compounds 4,[28] 6, 8, 10, 12, 14, 16, 18,[35]
and 19–21[28] were synthesised according to published procedures. The
syntheses of compounds 11, 11–Pd, 12–Pd, 13, 15, 17, 17–Pd and 18–Pd
are described in the Supporting Information. CH3CN and CHCl3 were
dried over molecular sieves; THF and CH2Cl2 were dried and distilled
over sodium and CaH2. Triethylamine was dried and distilled over KOH.
Analytical EtOH and MeOH were used without further purification. 1H
and 13C NMR spectra were recorded at 258C, unless stated otherwise, on
either Bruker AV300 (300 MHz), Bruker AV400 (400 MHz), Bruker
AV500 (500 MHz) or Bruker AV600 (600 MHz) spectrometers, with the
deuterated solvent as the lock and residual solvent as the internal refer-
ence. Absorption spectra were recorded by using a Uvikon XL spectro-
photometer. Melting points were measured by using a Stuart Scientific
Melting Point SMP-1 apparatus without further correction. MALDI-TOF
spectra were recorded on a Bruker autoflex II TOF TOF (equipped with
a nitrogen laser and used in reflectron mode) instrument with dithranol
(1,8,9-trihydroxyanthracene) as the matrix. A microTOF LC (Bruker
Daltonics, Bremen) spectrometer equipped with an electrospray source
was used for the electrospray mass spectrometry measurements.
AHCTUNGTRENNUNG
Hs, Hc), 9.00 (d, 3J
N
ACHTUNGTRENNUNG
3J
4J
(H,H)=4.7, 4J
E
ACHTUNGTRENNUNG
3
ACHTUNGTRENNUNG(H,H)=
4.8, 4J
U
signments according to HSQC and HMBC 2D 1H–13C NMR experi-
ments): 40.0 (Cq6), 66.9 (Cq1), 69.9 (Cq2), 70.4 (Cq5), 70.9 (Cq4, Cq3), 103.4
(Cp), 103.8 (Cm), 110.8 (Cn), 118.6 (Cj3), 122.4 (Ce2), 122.8 (Cc2, Cj2), 125.1
(Cs), 127.1 (Co), 127.4 (Ca, Ch), 128.9 (Cb, Cg), 130.1 (CL), 132.0 (CJ),
133.3 (Ce), 133.4 (Cd, Ci), 135.1 (Cc1), 135.4 (Cf), 135.5 (Cc), 139.3 (Ct),
140.8 (Ce3), 146.5 (Cj1), 147.2 (Cc3), 147.5 (Ci1), 147.9 (Ce1), 149.4 (Cs1),
149.6 (Ck), 164.2 ppm (Cs2) (labelling of the hydrogen and carbon atoms
is given in the Supporting Information); UV/VIS (CH2Cl2): lmax (e)=427
(390000), 561 (15000), 600 nm (6000 molÀ1 m3 cmÀ1); MALDI-TOF: m/z
(%): 1345.61 (33) [MÀH]+, 958.32 (53) [19ÀSnÀC14H10O3]+, 733.24 (14)
[19ÀSn]+.
Crystal data for 3: C78H72Cl8N8O10Sn; Mr =1683.73; purple crystal; 0.05ꢃ
¯
0.05ꢃ0.02 mm; triclinic; space group P1; a=9.8866(5), b=14.8757(8), c=
27.7531(14) ꢂ; a=90.905(3), b=95.079(3), g=108.221(3)8; V=
3857.7(3) ꢂ3; T=173(2) K; Z=2; 1calcd =1.450 gcmÀ3
; ;
m=0.672 mmÀ1
X-ray crystal-structure analyses: Data were collected on
a Bruker
28114 collected reflections, 15911 independent (RACHTNUTRGNEUNG(int)=0.0453), GooF=
SMART CCD diffractometer with MoKa radiation. The structures were
solved by using the SHELXS-97 program and refined by full-matrix least
squares on F2 using SHELXL-97 with anisotropic thermal parameters for
all non-hydrogen atoms. The hydrogen atoms were introduced at calcu-
lated positions and not refined (riding model). CCDC-803619 contains
the supplementary crystallographic data for this paper. These data can be
obtained free of charge from The Cambridge Crystallographic Data
1.167, R1=0.1073, wR2=0.2685 for I>2s(I) and R1=0.1458, wR2=
0.2918 for all data.
Synthesis of 3–Pd
Method A: Under argon, a solution of 18–Pd (10.5 mg, 0.013 mmol,
1.1 equiv) in distilled CH2Cl2 (25 mL) was added dropwise, by using a
cannula, to a solution of 21 (9.3 mg, 0.012 mmol, 1 equiv) in distilled
CH2Cl2 (10 mL). The resulting solution was stirred at room temperature
for 4 days. Evolution of the reaction was monitored by 1H NMR spectros-
copy. After removal of the solvent, a purple powder was obtained
(16.0 mg, 90%).
Synthesis of 2: Compound 21 (70 mg, 0.091 mmol, 1 equiv) was added as
a solid to a solution of 17 (51 mg, 0.097 mmol, 1.1 equiv) in CH2Cl2
(160 mL). The resulting solution was stirred at room temperature for
7 days. After removal of the solvent, the residue was recrystallised from
CH2Cl2/pentane (7 mL/50 mL) to afford a deep red powder (80 mg,
70%). 1H NMR (500 MHz, CD2Cl2) (assignments according to COSY
Method B: Et3N (25 mL, 0.182 mmol, 25 equiv) was added to a solution
of 3 (10 mg, 7.44ꢃ10À3 mmol, 1 equiv) in distilled CH2Cl2 (10 mL). A so-
(PF6)2 (4.2 mg, 7.44ꢃ10À3 mmol, 1 equiv) in dry
lution of [PdACHTNUTRGENNUG(CH3CN)4]ACHUTNGTRENNGUN
1
3
and ROESY 2D H–1H NMR experiments): d=1.17 (t, J
2H; Hm), 1.52 (ddd, 3J(H,H)=8.0, 4J(H,H)=2.1, 4J
(H,H)=0.9 Hz, 2H;
Hn), 3.09–3.15 (m, 4H; Hq1), 3.46–3.51 (m, 4H; Hq2), 3.62–3.66 (m, 4H;
q3), 3.67–3.73 (m, 4H; Hq4), 5.36 (ddd, 3J(H,H)=8.0, 4J
(H,H)=2.5,
(H,H)=0.9 Hz, 2H; Hp), 5.53 (t, 3J
(H,H)=8.0 Hz, 2H; Ho), 7.77–7.85
(m, 9H; Ha, Hb, Hg, Hh), 8.13–8.21 (m, 3H; HL, Hr, Ht), 8.21–8.27 (m,
3H; Hc and Hf), 8.45 (d, 3J(H,H)=7.9 Hz, 2H; Hs), 9.07 (dd, 3J
(H,H)=
4.2, 4J(H,H)=1.6 Hz, 2H; Hk), 9.10 (d, 3J
(H,H)=4.7 Hz, 2H; HJ), 9.17
(s, 4H; He, Hd), 9.18 ppm (d, 3J(H,H)=4.8 Hz, 2H; Hi); 13C NMR
ACHTUNGTREN(NUNG H,H)=2.3 Hz,
CH3CN (10 mL) was added dropwise to the mixture. The resulting mix-
ture was stirred at room temperature for 3 h. No colour change was ob-
served. The solvent was evaporated and the crude product was dissolved
in CH2Cl2 (2 mL) and precipitated upon addition of pentane (10 mL).
The violet powder was further recrystallised from CH2Cl2/pentane (3 mL/
15 mL) to afford the desired compound 3–Pd as a purple powder (9.2 mg,
85%). 1H NMR (500 MHz, CD2Cl2) (assignments according to COSY
G
E
ACHTUNGTRENNUNG
H
G
R
ACHTUNGTRENNUNG
4J
ACHTUNGTRENNUNG
E
ACHTUNGTRENNUNG
and ROESY 2D 1H-1H NMR experiments): d=1.15 (t, 4J
2H; Hm), 1.48 (dd, 3J(H,H)=7.7, 4J
(H,H)=1.7 Hz, 2H; Hn), 2.66 (m,
4H; Hq6), 3.28 (m, 4H; Hq1), 3.61 (m, 4H; Hq2), 3.68 (m, 4H; Hq3), 3.76
(m, 4H; Hq4), 3.97 (m, 4H; Hq5), 5.31 (m, 2H; Hp), 5.53 (t, 3J
(H,H)=
8.0 Hz, 2H; Ho), 7.68 (d, 3J
(H,H)=7.5 Hz, 2H; Hs), 7.80–7.89 (m, 9H;
Ha, Hb, Hg, Hh), 8.02 (t, 3J
(H,H)=7.7 Hz, 1H; Ht), 8.24 (m, 4H; Hf),
8.40–8.43 (m, 4H; HL, Hc), 8.89 (d, J ACTHNUTRGNEUNG(Sn,H)=17.0 Hz, 2H;
ACHTUNGTREN(NUNG H,H)=2.5 Hz,
G
ACHTUNGTRENNUNG
A
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
(125 MHz, CD2Cl2) (assignments according to HSQC and HMBC 2D
1H–13C NMR experiments): d=39.8 (Cq4), 65.9 (Cq1), 69.6 (Cq2), 69.8
(Cq3), 102.8 (Cm), 103.7 (Cp), 110.2 (Cn), 125.2 (Cs), 126.6 (Co), 127.0 (Ca,
Ch), 128.6 (Cb, Cg), 129.8 (CL), 131.7 (CJ), 132.8 (Cd, Ce), 139.1 (Ct), 140.3
(Cc1, Ce3), 146.2 (CJ1), 148.3 (CJ3), 148.7 (Ck), 155.6 (Cm1), 156.5 (Cm2),
163.4 ppm (Cs2) (labelling of the hydrogen and carbon atoms is given in
the Supporting Information); UV/VIS (CH2Cl2): lmax (e)=425 (330000),
561 (25000), 600 nm (14000 molÀ1 m3 cmÀ1); MALDI-TOF: m/z (%):
ACHTUNGTRENNUNG
AHCTUNGTRENNUNG
AHCTUNGTRENNUNG
3
4
U
HJ), 9.12 (d, 3J
(H,H)=4.5, 4J
E
3J
4J
A
U
ACHTUNGTRENNUNG
A
A
ACHTUNGTRENNUNG
6450
ꢁ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2011, 17, 6443 – 6452